SR

Sangram Rajendra Deshmukh

Active Director Director DIN 10365423
DIN 10365423 First appointment Oct 2023 Primary industry Paper
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Sangram Rajendra Deshmukh

Data last updated:

Sangram Rajendra Deshmukh is a Director at Cidon Pharma Private Limited (since 2023). The company operates in Paper.

DIN 10365423
Primary Designation Director
Industry Paper
First Appointment 20 Oct 2023
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Cidon Pharma Private Limited U21009PN2023PTC225064
Director20 Oct 20232023Active

Board colleagues of Sangram Rajendra Deshmukh

Directorship timeline

Open interactive timeline →
Cidon Pharma Private Limited
Premium access

Shareholding and investment profile for Sangram Rajendra Deshmukh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sangram Rajendra Deshmukh

Sangram Rajendra Deshmukh currently holds 1 directorship: Cidon Pharma Private Limited (Director, since 20 Oct 2023).

Sangram Rajendra Deshmukh was first appointed on 20 Oct 2023 as Director at Cidon Pharma Private Limited.

The current boards of Sangram Rajendra Deshmukh's companies include Atul Ankush Ghadage (Cidon Pharma Private Limited), Sachin Ramchandra Pawar (Cidon Pharma Private Limited), Sachin Subhash Ingawale (Cidon Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available